Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
EMA
Pharma
European regulators spurn Eisai and Biogen's Alzheimer's med
Despite winning approvals in a range of countries, Eisai and Biogen’s Alzheimer’s disease med Leqembi has come up short with European regulators.
Fraiser Kansteiner
Jul 26, 2024 9:42am
Mirati's flagship KRAS inhibitor Krazati gets rebuffed in Europe
Jul 21, 2023 12:20pm
Sanofi's Lemtrada goes under EU review for fatal side effects
Apr 15, 2019 11:35am
German regulators yank Dr. Reddy’s certificate from India plant
Aug 15, 2017 8:34am
Novartis' troubled Alcon unit recalls eye drops for sterility, potency problems; Endo tanks on women's health sale;
Mar 1, 2016 11:30am
